Abbott Freestyle Libre FDA Approved

Screen Shot 2017-10-01 at 12.59.18 PMPreviously available in Europe and Canada, the Freestyle Libre Flash Glucose Monitoring System was approved by the FDA last week.

From the press release:

The system reduces the need for fingerstick testing by using a small sensor wire inserted below the skin’s surface that continuously measures and monitors glucose levels. Users can determine glucose levels by waving a dedicated, mobile reader above the sensor wire to determine if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing. It is intended for use in people 18 years of age and older with diabetes; after a 12-hour start-up period, it can be worn for up to 10 days.

You can read the full release here.

What distinguishes this system is that is requires no finger stick calibration. Dosing can be made of its blood glucose measurements. To get a reading, the user waves the handheld reader over the sensor worn on the body that has a wire inserted under the skin. The reader reports bg levels as well as directional arrows and an 8 hour trend history.

The Libre Pro version was previously available in the US, but that allowed for medical professionals only to access the data. The Libre Flash now gives the user full access to information and its immediate use.

For more:

A Sweet Life

%d bloggers like this: